Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 1Gynecologic 1CNS 1

Conditions

Head and Neck Neoplasms 14Squamous Cell Carcinoma of Head and Neck 7Thyroid Neoplasms 6Tongue Neoplasms 4Salivary Gland Neoplasms 3Carcinoma, Squamous Cell 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Carcinoma, Medullary 2Adenocarcinoma, Follicular 2Xerostomia 1Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Neoplasms, Squamous Cell 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma 1Locally Advanced Thyroid Gland Carcinoma 1Hereditary Sensory and Autonomic Neuropathies 1Esthesioneuroblastoma, Olfactory 1Differentiated Thyroid Cancer 1Colonic Neoplasms 1

Interventions

pembrolizumab 7Cetuximab 5selpercatinib 3cemiplimab 3Trastuzumab 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Erlotinib Hydrochloride 3Bortezomib 3sargramostim 2motexafin gadolinium 2entinostat 2Specimen Handling 2Radiotherapy 2Oxaliplatin 2Irinotecan 2Fluorodeoxyglucose F18 2Drug Therapy 2Docetaxel 2Biopsy 2ulixertinib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1tipifarnib 1tanespimycin 1spartalizumab 1serabelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Everolimus × Head & Neck × Clear all
NCT01637194 2012-07-11

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Fox Chase Cancer Center

Phase 1 Completed
12 enrolled
CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡